305 related articles for article (PubMed ID: 36326373)
1. Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center.
Öztaş M; Özgül H; Seyahi E; Uğurlu S
Turk J Med Sci; 2022 Aug; 52(4):917-925. PubMed ID: 36326373
[TBL] [Abstract][Full Text] [Related]
2. Giant cell arteritis and polymyalgia rheumatica: an update.
González-Gay MA; Pina T
Curr Rheumatol Rep; 2015 Feb; 17(2):6. PubMed ID: 25618572
[TBL] [Abstract][Full Text] [Related]
3. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
Schmidt J; Warrington KJ
Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
[TBL] [Abstract][Full Text] [Related]
4. Polymyalgia rheumatica and giant cell arteritis-three challenges-consequences of the vasculitis process, osteoporosis, and malignancy: A prospective cohort study protocol.
Emamifar A; Hess S; Gerke O; Hermann AP; Laustrup H; Hansen PS; Thye-Rønn P; Marcussen N; Svendstrup F; Gildberg-Mortensen R; Bang JC; Farahani ZA; Chrysidis S; Toftegaard P; Andreasen RA; le Greves S; Andersen HR; Olsen RN; Hansen IMJ
Medicine (Baltimore); 2017 Jun; 96(26):e7297. PubMed ID: 28658131
[TBL] [Abstract][Full Text] [Related]
5. Myalgias and Myopathies: Polymyalgia Rheumatica and Giant Cell Arteritis.
Mansalis K
FP Essent; 2016 Jan; 440():16-22. PubMed ID: 26734832
[TBL] [Abstract][Full Text] [Related]
6. Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database.
Albrecht K; Huscher D; Buttgereit F; Aringer M; Hoese G; Ochs W; Thiele K; Zink A
Rheumatol Int; 2018 Apr; 38(4):569-577. PubMed ID: 29124397
[TBL] [Abstract][Full Text] [Related]
7. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
[TBL] [Abstract][Full Text] [Related]
8. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
Pioro MH
Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
[TBL] [Abstract][Full Text] [Related]
9. [Management of polymyalgia rheumatica and large vessel vasculitis].
Hellmich B
Internist (Berl); 2016 Nov; 57(11):1069-1078. PubMed ID: 27631531
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of polymyalgia rheumatica and giant cell arteritis.
Salvarani C; Pipitone N; Versari A; Hunder GG
Nat Rev Rheumatol; 2012 Sep; 8(9):509-21. PubMed ID: 22825731
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis.
Emamifar A; Ellingsen T; Hermann AP; Hess S; Gerke O; Ahangarani Farahani Z; Syrak Hansen P; Jensen Hansen IM; Thye-Rønn P
Sci Rep; 2021 Mar; 11(1):6220. PubMed ID: 33737697
[TBL] [Abstract][Full Text] [Related]
12. [Polymyalgia rheumatica and temporal arteritis].
Vos PA; Bijlsma JW; Derksen RH
Ned Tijdschr Geneeskd; 2005 Aug; 149(35):1932-7. PubMed ID: 16159030
[TBL] [Abstract][Full Text] [Related]
13. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
Lally L; Spiera R
Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
[TBL] [Abstract][Full Text] [Related]
14. Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
Salvarani C; Padoan R; Iorio L; Tomelleri A; Terrier B; Muratore F; Dasgupta B
Autoimmun Rev; 2024 Jan; 23(1):103415. PubMed ID: 37625672
[TBL] [Abstract][Full Text] [Related]
15. Positron Emission Tomography/Computerized Tomography in Newly Diagnosed Patients with Giant Cell Arteritis Who Are Taking Glucocorticoids.
Clifford AH; Murphy EM; Burrell SC; Bligh MP; MacDougall RF; Heathcote JG; Castonguay MC; Lee MS; Matheson K; Hanly JG
J Rheumatol; 2017 Dec; 44(12):1859-1866. PubMed ID: 28916549
[TBL] [Abstract][Full Text] [Related]
16. HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
Kushimoto K; Ayano M; Nishimura K; Nakano M; Kimoto Y; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
Arthritis Res Ther; 2021 Sep; 23(1):238. PubMed ID: 34517892
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
[TBL] [Abstract][Full Text] [Related]
18. [A case of giant cell arteritis after prednisolone dose reduction during treatment of polymyalgia rheumatica].
Yamashita M; Aoki A; Kobayashi H; Wakiya M; Nakatsugawa M
Nihon Ronen Igakkai Zasshi; 2023; 60(4):440-447. PubMed ID: 38171762
[TBL] [Abstract][Full Text] [Related]
19. The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis.
Jakobsson K; Jacobsson L; Mohammad AJ; Nilsson JÅ; Warrington K; Matteson EL; Turesson C
BMC Musculoskelet Disord; 2016 Aug; 17(1):363. PubMed ID: 27558589
[TBL] [Abstract][Full Text] [Related]
20. Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
Esen I; Arends S; Dalsgaard Nielsen B; Therkildsen P; Hansen I; van 't Ende A; Heeringa P; Boots A; Hauge E; Brouwer E; van Sleen Y
RMD Open; 2023 Jan; 9(1):. PubMed ID: 36631159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
